- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
The president’s plan for Medicare to pay no more for prescription drugs than the governments of other developed countries may not work in some instances because drug companies could find ways to sell drugs here that aren’t available abroad and therefore don’t have an international reference price, according to drug price watchdog 46Brooklyn.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us